The global market for Biomarker of Disease was valued at US$ 32340 million in the year 2024 and is projected to reach a revised size of US$ 89610 million by 2031, growing at a CAGR of 15.9% during the forecast period.

Biomarker of Disease Market

Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drug.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Biomarker of Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker of Disease.

The Biomarker of Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker of Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biomarker of Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biomarker of Disease Market Report

Report Metric	Details
Report Name	Biomarker of Disease Market
Accounted market size in year	US$ 32340 million
Forecasted market size in 2031	US$ 89610 million
CAGR	15.9%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Sample Preparation Assay Development Biomarker Validation and Testing Others
Segment by Application	Pharmaceutical Companies Government & Private Research Institutes Academic Institutes Medical Device Manufacturing Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aushon Biosystem, Bio-Rad Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Eisai Co. Ltd, Roche Diagnostics Limited, Abbott Laboratories, Inc, Epistem Ltd, Ge Healthcare, Agilent Technologies Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker of Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biomarker of Disease Market growing?

Ans: The Biomarker of Disease Market witnessing a CAGR of 15.9% during the forecast period 2026-2031.

What is the Biomarker of Disease Market size in 2031?

Ans: The Biomarker of Disease Market size in 2031 will be US$ 89610 million.

Who are the main players in the Biomarker of Disease Market report?

Ans: The main players in the Biomarker of Disease Market are Aushon Biosystem, Bio-Rad Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Eisai Co. Ltd, Roche Diagnostics Limited, Abbott Laboratories, Inc, Epistem Ltd, Ge Healthcare, Agilent Technologies Inc

What are the Application segmentation covered in the Biomarker of Disease Market report?

Ans: The Applications covered in the Biomarker of Disease Market report are Pharmaceutical Companies, Government & Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies, Others

What are the Type segmentation covered in the Biomarker of Disease Market report?

Ans: The Types covered in the Biomarker of Disease Market report are Sample Preparation, Assay Development, Biomarker Validation and Testing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biomarker of Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Sample Preparation

1.2.3 Assay Development

1.2.4 Biomarker Validation and Testing

1.2.5 Others

1.3 Market by Application

1.3.1 Global Biomarker of Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Government & Private Research Institutes

1.3.4 Academic Institutes

1.3.5 Medical Device Manufacturing Companies

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biomarker of Disease Market Perspective (2020-2031)

2.2 Global Biomarker of Disease Growth Trends by Region

2.2.1 Global Biomarker of Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biomarker of Disease Historic Market Size by Region (2020-2025)

2.2.3 Biomarker of Disease Forecasted Market Size by Region (2026-2031)

2.3 Biomarker of Disease Market Dynamics

2.3.1 Biomarker of Disease Industry Trends

2.3.2 Biomarker of Disease Market Drivers

2.3.3 Biomarker of Disease Market Challenges

2.3.4 Biomarker of Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biomarker of Disease Players by Revenue

3.1.1 Global Top Biomarker of Disease Players by Revenue (2020-2025)

3.1.2 Global Biomarker of Disease Revenue Market Share by Players (2020-2025)

3.2 Global Biomarker of Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biomarker of Disease Revenue

3.4 Global Biomarker of Disease Market Concentration Ratio

3.4.1 Global Biomarker of Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biomarker of Disease Revenue in 2024

3.5 Global Key Players of Biomarker of Disease Head office and Area Served

3.6 Global Key Players of Biomarker of Disease, Product and Application

3.7 Global Key Players of Biomarker of Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker of Disease Breakdown Data by Type

4.1 Global Biomarker of Disease Historic Market Size by Type (2020-2025)

4.2 Global Biomarker of Disease Forecasted Market Size by Type (2026-2031)

5 Biomarker of Disease Breakdown Data by Application

5.1 Global Biomarker of Disease Historic Market Size by Application (2020-2025)

5.2 Global Biomarker of Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biomarker of Disease Market Size (2020-2031)

6.2 North America Biomarker of Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biomarker of Disease Market Size by Country (2020-2025)

6.4 North America Biomarker of Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biomarker of Disease Market Size (2020-2031)

7.2 Europe Biomarker of Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biomarker of Disease Market Size by Country (2020-2025)

7.4 Europe Biomarker of Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biomarker of Disease Market Size (2020-2031)

8.2 Asia-Pacific Biomarker of Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biomarker of Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Biomarker of Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biomarker of Disease Market Size (2020-2031)

9.2 Latin America Biomarker of Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biomarker of Disease Market Size by Country (2020-2025)

9.4 Latin America Biomarker of Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biomarker of Disease Market Size (2020-2031)

10.2 Middle East & Africa Biomarker of Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biomarker of Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Biomarker of Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aushon Biosystem

11.1.1 Aushon Biosystem Company Details

11.1.2 Aushon Biosystem Business Overview

11.1.3 Aushon Biosystem Biomarker of Disease Introduction

11.1.4 Aushon Biosystem Revenue in Biomarker of Disease Business (2020-2025)

11.1.5 Aushon Biosystem Recent Development

11.2 Bio-Rad Laboratories

11.2.1 Bio-Rad Laboratories Company Details

11.2.2 Bio-Rad Laboratories Business Overview

11.2.3 Bio-Rad Laboratories Biomarker of Disease Introduction

11.2.4 Bio-Rad Laboratories Revenue in Biomarker of Disease Business (2020-2025)

11.2.5 Bio-Rad Laboratories Recent Development

11.3 Thermo Fisher Scientific Inc

11.3.1 Thermo Fisher Scientific Inc Company Details

11.3.2 Thermo Fisher Scientific Inc Business Overview

11.3.3 Thermo Fisher Scientific Inc Biomarker of Disease Introduction

11.3.4 Thermo Fisher Scientific Inc Revenue in Biomarker of Disease Business (2020-2025)

11.3.5 Thermo Fisher Scientific Inc Recent Development

11.4 Siemens AG

11.4.1 Siemens AG Company Details

11.4.2 Siemens AG Business Overview

11.4.3 Siemens AG Biomarker of Disease Introduction

11.4.4 Siemens AG Revenue in Biomarker of Disease Business (2020-2025)

11.4.5 Siemens AG Recent Development

11.5 Eisai Co. Ltd

11.5.1 Eisai Co. Ltd Company Details

11.5.2 Eisai Co. Ltd Business Overview

11.5.3 Eisai Co. Ltd Biomarker of Disease Introduction

11.5.4 Eisai Co. Ltd Revenue in Biomarker of Disease Business (2020-2025)

11.5.5 Eisai Co. Ltd Recent Development

11.6 Roche Diagnostics Limited

11.6.1 Roche Diagnostics Limited Company Details

11.6.2 Roche Diagnostics Limited Business Overview

11.6.3 Roche Diagnostics Limited Biomarker of Disease Introduction

11.6.4 Roche Diagnostics Limited Revenue in Biomarker of Disease Business (2020-2025)

11.6.5 Roche Diagnostics Limited Recent Development

11.7 Abbott Laboratories, Inc

11.7.1 Abbott Laboratories, Inc Company Details

11.7.2 Abbott Laboratories, Inc Business Overview

11.7.3 Abbott Laboratories, Inc Biomarker of Disease Introduction

11.7.4 Abbott Laboratories, Inc Revenue in Biomarker of Disease Business (2020-2025)

11.7.5 Abbott Laboratories, Inc Recent Development

11.8 Epistem Ltd

11.8.1 Epistem Ltd Company Details

11.8.2 Epistem Ltd Business Overview

11.8.3 Epistem Ltd Biomarker of Disease Introduction

11.8.4 Epistem Ltd Revenue in Biomarker of Disease Business (2020-2025)

11.8.5 Epistem Ltd Recent Development

11.9 Ge Healthcare

11.9.1 Ge Healthcare Company Details

11.9.2 Ge Healthcare Business Overview

11.9.3 Ge Healthcare Biomarker of Disease Introduction

11.9.4 Ge Healthcare Revenue in Biomarker of Disease Business (2020-2025)

11.9.5 Ge Healthcare Recent Development

11.10 Agilent Technologies Inc

11.10.1 Agilent Technologies Inc Company Details

11.10.2 Agilent Technologies Inc Business Overview

11.10.3 Agilent Technologies Inc Biomarker of Disease Introduction

11.10.4 Agilent Technologies Inc Revenue in Biomarker of Disease Business (2020-2025)

11.10.5 Agilent Technologies Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Aushon BioSystem

Bio Rad Laboratories

Thermo Fisher Scientific Inc

Siemens AG

Eisai Co Ltd

Roche Diagnostics Limited

Abbott Laboratories Inc

Epistem

GE Healthcare

Agilent Technologies Inc

List of Tables

Table 1. Global Biomarker of Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Sample Preparation

Table 3. Key Players of Assay Development

Table 4. Key Players of Biomarker Validation and Testing

Table 5. Key Players of Others

Table 6. Global Biomarker of Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Biomarker of Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Biomarker of Disease Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Biomarker of Disease Market Share by Region (2020-2025)

Table 10. Global Biomarker of Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Biomarker of Disease Market Share by Region (2026-2031)

Table 12. Biomarker of Disease Market Trends

Table 13. Biomarker of Disease Market Drivers

Table 14. Biomarker of Disease Market Challenges

Table 15. Biomarker of Disease Market Restraints

Table 16. Global Biomarker of Disease Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Biomarker of Disease Market Share by Players (2020-2025)

Table 18. Global Top Biomarker of Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker of Disease as of 2024)

Table 19. Ranking of Global Top Biomarker of Disease Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Biomarker of Disease Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Biomarker of Disease, Headquarters and Area Served

Table 22. Global Key Players of Biomarker of Disease, Product and Application

Table 23. Global Key Players of Biomarker of Disease, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Biomarker of Disease Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Biomarker of Disease Revenue Market Share by Type (2020-2025)

Table 27. Global Biomarker of Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Biomarker of Disease Revenue Market Share by Type (2026-2031)

Table 29. Global Biomarker of Disease Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Biomarker of Disease Revenue Market Share by Application (2020-2025)

Table 31. Global Biomarker of Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Biomarker of Disease Revenue Market Share by Application (2026-2031)

Table 33. North America Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Biomarker of Disease Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Biomarker of Disease Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Biomarker of Disease Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Biomarker of Disease Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Biomarker of Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Biomarker of Disease Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Biomarker of Disease Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Biomarker of Disease Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Biomarker of Disease Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Biomarker of Disease Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Biomarker of Disease Market Size by Country (2026-2031) & (US$ Million)

Table 48. Aushon Biosystem Company Details

Table 49. Aushon Biosystem Business Overview

Table 50. Aushon Biosystem Biomarker of Disease Product

Table 51. Aushon Biosystem Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 52. Aushon Biosystem Recent Development

Table 53. Bio-Rad Laboratories Company Details

Table 54. Bio-Rad Laboratories Business Overview

Table 55. Bio-Rad Laboratories Biomarker of Disease Product

Table 56. Bio-Rad Laboratories Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 57. Bio-Rad Laboratories Recent Development

Table 58. Thermo Fisher Scientific Inc Company Details

Table 59. Thermo Fisher Scientific Inc Business Overview

Table 60. Thermo Fisher Scientific Inc Biomarker of Disease Product

Table 61. Thermo Fisher Scientific Inc Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 62. Thermo Fisher Scientific Inc Recent Development

Table 63. Siemens AG Company Details

Table 64. Siemens AG Business Overview

Table 65. Siemens AG Biomarker of Disease Product

Table 66. Siemens AG Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 67. Siemens AG Recent Development

Table 68. Eisai Co. Ltd Company Details

Table 69. Eisai Co. Ltd Business Overview

Table 70. Eisai Co. Ltd Biomarker of Disease Product

Table 71. Eisai Co. Ltd Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 72. Eisai Co. Ltd Recent Development

Table 73. Roche Diagnostics Limited Company Details

Table 74. Roche Diagnostics Limited Business Overview

Table 75. Roche Diagnostics Limited Biomarker of Disease Product

Table 76. Roche Diagnostics Limited Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 77. Roche Diagnostics Limited Recent Development

Table 78. Abbott Laboratories, Inc Company Details

Table 79. Abbott Laboratories, Inc Business Overview

Table 80. Abbott Laboratories, Inc Biomarker of Disease Product

Table 81. Abbott Laboratories, Inc Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 82. Abbott Laboratories, Inc Recent Development

Table 83. Epistem Ltd Company Details

Table 84. Epistem Ltd Business Overview

Table 85. Epistem Ltd Biomarker of Disease Product

Table 86. Epistem Ltd Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 87. Epistem Ltd Recent Development

Table 88. Ge Healthcare Company Details

Table 89. Ge Healthcare Business Overview

Table 90. Ge Healthcare Biomarker of Disease Product

Table 91. Ge Healthcare Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 92. Ge Healthcare Recent Development

Table 93. Agilent Technologies Inc Company Details

Table 94. Agilent Technologies Inc Business Overview

Table 95. Agilent Technologies Inc Biomarker of Disease Product

Table 96. Agilent Technologies Inc Revenue in Biomarker of Disease Business (2020-2025) & (US$ Million)

Table 97. Agilent Technologies Inc Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Biomarker of Disease Picture

Figure 2. Global Biomarker of Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biomarker of Disease Market Share by Type: 2024 VS 2031

Figure 4. Sample Preparation Features

Figure 5. Assay Development Features

Figure 6. Biomarker Validation and Testing Features

Figure 7. Others Features

Figure 8. Global Biomarker of Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Biomarker of Disease Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Companies Case Studies

Figure 11. Government & Private Research Institutes Case Studies

Figure 12. Academic Institutes Case Studies

Figure 13. Medical Device Manufacturing Companies Case Studies

Figure 14. Others Case Studies

Figure 15. Biomarker of Disease Report Years Considered

Figure 16. Global Biomarker of Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Biomarker of Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Biomarker of Disease Market Share by Region: 2024 VS 2031

Figure 19. Global Biomarker of Disease Market Share by Players in 2024

Figure 20. Global Top Biomarker of Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker of Disease as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Biomarker of Disease Revenue in 2024

Figure 22. North America Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Biomarker of Disease Market Share by Country (2020-2031)

Figure 24. United States Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Biomarker of Disease Market Share by Country (2020-2031)

Figure 28. Germany Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Biomarker of Disease Market Share by Region (2020-2031)

Figure 36. China Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Biomarker of Disease Market Share by Country (2020-2031)

Figure 44. Mexico Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Biomarker of Disease Market Share by Country (2020-2031)

Figure 48. Turkey Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Biomarker of Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Aushon Biosystem Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 53. Thermo Fisher Scientific Inc Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 54. Siemens AG Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 55. Eisai Co. Ltd Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 56. Roche Diagnostics Limited Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 57. Abbott Laboratories, Inc Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 58. Epistem Ltd Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 59. Ge Healthcare Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 60. Agilent Technologies Inc Revenue Growth Rate in Biomarker of Disease Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions